The efficacy of hyperthermia-based multimodal therapy is dependent on gatekeeper protein, BID. - Helmueller S; Song X; Kim DH; Lee YJ (International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group, 2025)